Elevated levels of leptin can potentially accelerate the progression of obesity-related lung cancer through the activation of the STAT1- solute carrier family 7 member 11 (SLC7A11) pathway, which mediates ferroptosis. Here, SLC17A1 is linked to lung carcinoma.